XJPX4107
Market cap968mUSD
Dec 24, Last price
29,870.00JPY
1D
0.57%
1Q
50.63%
Jan 2017
1,109.31%
Name
Ise Chemicals Corp
Chart & Performance
Profile
ISE Chemicals Corporation engages in the production, processing, and trade of iodine and iodine derivatives, and nickel and cobalt compounds in Japan. The company offers iodine for use in X-ray contrast media, polarizing films, disinfectants, catalysts, stabilizers, pharmaceuticals, sodium additives, feed additives, and other applications; and cobalt and nickel compounds for use in electronic components. It also extracts and supplies natural gas to gas companies and factories. The company was founded in 1927 and is headquartered in Tokyo, Japan. ISE Chemicals Corporation is a subsidiary of AGC Inc.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | |||||
Revenues | 26,413,000 3.32% | 25,564,000 25.60% | 20,354,000 20.73% | ||
Cost of revenue | 21,076,000 | 21,776,000 | 16,170,000 | ||
Unusual Expense (Income) | |||||
NOPBT | 5,337,000 | 3,788,000 | 4,184,000 | ||
NOPBT Margin | 20.21% | 14.82% | 20.56% | ||
Operating Taxes | 1,527,000 | 1,036,000 | 818,000 | ||
Tax Rate | 28.61% | 27.35% | 19.55% | ||
NOPAT | 3,810,000 | 2,752,000 | 3,366,000 | ||
Net income | 3,672,000 43.33% | 2,562,000 44.50% | 1,773,000 32.02% | ||
Dividends | (1,121,000) | (739,000) | (509,000) | ||
Dividend yield | 2.56% | 2.70% | 2.61% | ||
Proceeds from repurchase of equity | (7,000) | (2,000) | (2,000) | ||
BB yield | 0.02% | 0.01% | 0.01% | ||
Debt | |||||
Debt current | 619,000 | 615,000 | 613,000 | ||
Long-term debt | 93,000 | 57,000 | 51,000 | ||
Deferred revenue | (144,000) | (126,000) | |||
Other long-term liabilities | 1,348,000 | 1,692,000 | 1,652,000 | ||
Net debt | (9,145,000) | (7,762,000) | (5,659,000) | ||
Cash flow | |||||
Cash from operating activities | 4,369,000 | 2,144,000 | 3,288,000 | ||
CAPEX | (1,879,000) | (2,101,000) | (3,297,000) | ||
Cash from investing activities | (1,911,000) | (2,112,000) | (7,259,000) | ||
Cash from financing activities | (1,150,000) | (757,000) | (526,000) | ||
FCF | 1,771,000 | 2,833,000 | 4,782,000 | ||
Balance | |||||
Cash | 9,720,000 | 8,387,000 | 6,276,000 | ||
Long term investments | 137,000 | 47,000 | 47,000 | ||
Excess cash | 8,536,350 | 7,155,800 | 5,305,300 | ||
Stockholders' equity | 27,743,000 | 25,413,000 | 23,368,000 | ||
Invested Capital | 25,358,650 | 23,444,200 | 23,608,700 | ||
ROIC | 15.61% | 11.70% | 13.86% | ||
ROCE | 15.75% | 12.32% | 14.41% | ||
EV | |||||
Common stock shares outstanding | 5,097 | 5,098 | 5,098 | ||
Price | 8,590.00 60.26% | 5,360.00 40.31% | 3,820.00 16.46% | ||
Market cap | 43,783,230 60.23% | 27,325,494 40.32% | 19,474,360 16.44% | ||
EV | 34,638,230 | 19,563,494 | 13,861,360 | ||
EBITDA | 7,307,000 | 5,600,000 | 5,673,000 | ||
EV/EBITDA | 4.74 | 3.49 | 2.44 | ||
Interest | 1,000 | 1,000 | 1,000 | ||
Interest/NOPBT | 0.02% | 0.03% | 0.02% |